Helping organizations be more effective and more efficient in getting transformative drugs to patients
A New Beginning
Helping organizations be more effective and more efficient in getting transformative drugs to patients
Helping industry and advocacy organizations better serve their rare disease communities
Developing neurocognitive and behavioral outcome measures that capture what patients care about and what industry needs for drug approval and access